GSKGlaxoSmithKlineFinished
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)
Neoplasms
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2
- Patients
- 175 (final count)
- Started
- Jan 24, 2019
- Main results expected
- May 2, 2024
- Fully finished
- May 2, 2024
- Results posted
- Jun 15, 2025
What counts as success
The trial's main goal(s), called the “primary outcome.”
Number of Participants Randomized Across Sub-studies
Measured over: Day 1
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT03739710 · record last updated 2025-06-15 · checked 2026-11-09 15:47 UTC